Hostname: page-component-77c89778f8-cnmwb Total loading time: 0 Render date: 2024-07-17T13:46:40.247Z Has data issue: false hasContentIssue false

Screening for Birth Defects: A Professional Liability Alert

Published online by Cambridge University Press:  28 April 2021

Aubrey Milunsky*
Affiliation:
American Society of Law & Medicine

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
President's Column
Copyright
Copyright © American Society of Law, Medicine and Ethics 1985

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

United Kingdom Collaborative Study on Alpha-Fetoprotein in Relation to Neural-Tube Defects, Maternal Serum-Alpha-Fetoprotein Measurement in Antenatal Screening for Anencephaly and Spina Bifida in Early Pregnancy, Lancet 1(8026): 1323–32 (June 25, 1977); Milunsky, A., Prenatal Detection of Neural Tube Defects: VI, Experience with 20,000 Pregnancies, Journal of the American Medical Association 244(24): 2731–35 (December 19, 1980); Milunsky, A. Alpert, E., Results and Benefits of a Maternal Serum Alpha-Fetoprotein Screening Program, Journal of the American Medical Association 252(11): 1438–42 (September 21, 1984).Google Scholar
Cuckle, H.S., Wald, N.J., Lindenbaum, R.H., Maternal Serum Alpha-Fetoprotein Measurement: A Screening Test for Down Syndrome, Lancet 1(8383): 926–29 (April 28, 1984).Google ScholarPubMed